Dr. Dy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
elm and carlton street
Buffalo, NY 14263Phone+1 716-845-3099
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2003 - 2007- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2000 - 2003
University of Santo TomasClass of 1998
Publications & Presentations
PubMed
- Divergent transcriptional states and kinetics of circulating tumor-infiltrating lymphocyte repertoires with highly homologous T-cell receptor sequences in a patient du...Ryutaro Kajihara, Mark D Long, Toshifumi Hoki, Hongbin Chen, Takayoshi Yamauchi
Journal for Immunotherapy of Cancer. 2025-01-25 - A phase I study of the CDK4/6 inhibitor ribociclib combined with gemcitabine in patients with advanced solid tumors.Aurora Norman, Mahesh Seetharam, Jacob Allred, Jianping Kong, Mateusz Opyrchal
BJC Reports. 2025-01-14 - Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced so...Diwakar Davar, Benedito A Carneiro, Grace K Dy, Siddharth Sheth, Mitesh J Borad
Journal for Immunotherapy of Cancer. 2024-11-17
Press Mentions
Mesothelioma Treatment Center Marks 20th Year of Precision Medicine TreatmentNovember 19th, 2024- Should First-Line Dual Checkpoint Blockade Be Used for NSCLC with Specific Mutations?October 24th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
